ArticleScientific reports2015

The multi-targeted tyrosine kinase inhibitor vandetanib plays a bifunctional role in non-small cell lung cancer cells.

Yan Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.